Lumawan, Kerian Von A.
HRN: 21-34-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/27/2022
12/04/2022
ORAL
5 Ml
8 Hrs
AGE W/ Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes